Cone Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

We're delivering into the body. in addition, at meira, we've actually developed, over the last seven years, a totally new technology which allows us to, in the future, control how those genes delivered to the body are activated using pills. one of the six clinical trials taking place here is targeting an inherited eye condition called retinitis pigmentosa. it causes light—detecting cells in the retina to break down over time, causing a person to eventually lose vision. red are the rod cells and green are the cone cells, so they exist in this kind of mosaic. early results of using gene therap...

Started, one of the big issues was how do you get those genes into people? so we, and others, over the last five to ten years, have developed a new viral vector, and we're manufacturing that here to deliver the genes we're delivering into the body. in addition, at meira, we've actually developed, over the last seven years, a totally new technology which allows us to, in the future, control how those genes delivered to the body are activated using pills. one of the six clinical trials taking place here is targeting an inherited eye condition called retinitis pigmentosa. it causes light—detect...

Here to deliver the genes we're delivering into the body. in addition, at meira, we've actually developed, over the last seven years, a totally new technology which allows us to, in the future, control how those genes delivered to the body are activated using pills. one of the six clinical trials taking place here is targeting an inherited eye condition called retinitis pigmentosa. it causes light—detecting cells in the retina to break down over time, causing a person to eventually lose vision. red are the rod cells and green are the cone cells, so they exist in this kind of mosaic. early re...

That here to deliver the genes we're delivering into the body. in addition, at meira, we've actually developed, over the last seven years, a totally new technology which allows us to, in the future, control how those genes delivered to the body are activated using pills. one of the six clinical trials taking place here is targeting an inherited eye condition called retinitis pigmentosa. it causes light—detecting cells in the retina to break down over time, causing a person to eventually lose vision. red are the rod cells and green are the cone cells, so they exist in this kind of mosaic. ear...

And green are the cone cells, so they exist in this kind of mosaic. early results of using gene therapy to treat retinitis pigmentosa has shown that it could potentially not only slow the progression of the disease, but in some cases reverse some of its effects. the work being done here has real potential to change the lives of people with inherited conditions. the challenge is taking it out of a laboratory like this and getting it to those people that really need it. the retinitis pigmentosa research is being carried out with pharmaceutical companyjohnson &johnson and is currently in stage th...